AU2001236887A1 - Antibody binding superficial zone protein and their uses in diagnosis and screening methods - Google Patents

Antibody binding superficial zone protein and their uses in diagnosis and screening methods

Info

Publication number
AU2001236887A1
AU2001236887A1 AU2001236887A AU3688701A AU2001236887A1 AU 2001236887 A1 AU2001236887 A1 AU 2001236887A1 AU 2001236887 A AU2001236887 A AU 2001236887A AU 3688701 A AU3688701 A AU 3688701A AU 2001236887 A1 AU2001236887 A1 AU 2001236887A1
Authority
AU
Australia
Prior art keywords
diagnosis
antibody binding
screening methods
superficial zone
zone protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236887A
Inventor
Jeff T. Hutchins
Klaus E. Kuettner
Kathryn Mason Lindley
Thomas M. Schmid
Barbara L. Schumacher
Stephen Anthony Stimpson
Jui-Lan Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Rush Presbyterian St Lukes Medical Center
Original Assignee
Glaxo Group Ltd
Rush Presbyterian St Lukes Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Rush Presbyterian St Lukes Medical Center filed Critical Glaxo Group Ltd
Priority claimed from PCT/US2001/004372 external-priority patent/WO2001058958A1/en
Publication of AU2001236887A1 publication Critical patent/AU2001236887A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU2001236887A 2000-02-09 2001-02-09 Antibody binding superficial zone protein and their uses in diagnosis and screening methods Abandoned AU2001236887A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US60/181,377 2000-02-09
GBGB0003092.4A GB0003092D0 (en) 2000-02-10 2000-02-10 Superficial zone protein-binding molecules and uses thereof
GB0003092.4 2000-02-10
US60/201,989 2000-05-03
PCT/US2001/004372 WO2001058958A1 (en) 2000-02-09 2001-02-09 Antibody binding superficial zone protein and their uses in diagnosis and screening methods

Publications (1)

Publication Number Publication Date
AU2001236887A1 true AU2001236887A1 (en) 2001-08-20

Family

ID=9885347

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236887A Abandoned AU2001236887A1 (en) 2000-02-09 2001-02-09 Antibody binding superficial zone protein and their uses in diagnosis and screening methods

Country Status (3)

Country Link
US (2) US6720156B2 (en)
AU (1) AU2001236887A1 (en)
GB (1) GB0003092D0 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US20060240037A1 (en) * 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
US20090155200A1 (en) * 2004-04-20 2009-06-18 Jay Gregory D Methods of promoting cartilage healing or cartilage integration
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
WO2006012492A2 (en) * 2004-07-23 2006-02-02 Mucosal Therapeutics Llc Compositions and methods for viscosupplementation
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20080139458A1 (en) * 2004-12-03 2008-06-12 Jay Gregory D Methods of Treatment For Injured or Diseased Joints
US20070111327A1 (en) * 2005-05-05 2007-05-17 Jay Gregory D Methods of detecting lubricin
MX2008013394A (en) * 2006-04-21 2008-10-31 Wyeth Corp Methods for high-throughput screening of cell lines.
US20080214417A1 (en) * 2007-02-07 2008-09-04 University Of Waterloo Lubricant for wear testing of joint replacements and associated materials
US20090068247A1 (en) * 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US9264184B2 (en) * 2009-10-30 2016-02-16 Sony Corporation Coordinated signaling of scheduling information for uplink and downlink communications
EP3420354A1 (en) 2016-02-23 2019-01-02 Lynxon AB Method of diagnosing arthritis or other joint degrading disease
CN110514821A (en) * 2019-05-22 2019-11-29 武汉三鹰生物技术有限公司 A kind of protein immunoblotting film is lived again liquid and its application method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277975B1 (en) 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins

Also Published As

Publication number Publication date
GB0003092D0 (en) 2000-03-29
US20050089881A1 (en) 2005-04-28
US6720156B2 (en) 2004-04-13
US20020009761A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2001255436A1 (en) Protein expression system arrays and use in biological screening
ZA200206266B (en) Antibodies that bind human interleukin-18 and methods of making and using.
IL145134A (en) Human antibodies that bind human il-12 and methods for producing them
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
IL151853A (en) Multivalent antibodies and uses thereof
EP1551447A4 (en) Anti-addl antibodies and uses thereof
AU2002338015A1 (en) Human CDR-grafted antibodies and antibody fragments thereof
GB0029360D0 (en) Humanised antibodies and uses thereof
AU2001236887A1 (en) Antibody binding superficial zone protein and their uses in diagnosis and screening methods
AU6768301A (en) Materials and methods relating to the increase in protein activity
IL152725A0 (en) Human receptor proteins, related reagents and methods
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU2608602A (en) Silensed anti-cd28 antibodies and use thereof
IL153539A0 (en) Protein complexes and methods for the preparation thereof
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
IL166063A0 (en) Antibodies and uses thereof
AU2001274566A1 (en) Novel protein and dna thereof
EP1302770A4 (en) Particle-labeled protein and immuno-chromatograph using the same
EP1294738A4 (en) Novel motor proteins and methods for their use
AU2001261534A1 (en) The meca-79 antigen and related methods
EP1290151A4 (en) Novel motor proteins and methods for their use
AU2001269078A1 (en) Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods
AU1551800A (en) Antibodies, mini-antibodies or antibody fragments binding to vitamin e and the use thereof
AU2002245196A1 (en) Assembly and screening of highly complex and fully human antibody repertoire in yeast